Great Tree Pharmacy Co., Ltd. - Laporan Laba Rugi (TTM)

Great Tree Pharmacy Co., Ltd.
TW ˙ TPEX ˙ TW0006469000
NT$ 181.00 ↓ -2.00 (-1.09%)
2024-10-25
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Great Tree Pharmacy Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 8,079 8,641 9,108 9,954 10,617 11,281 11,993 13,124 13,827 14,565 15,185 15,294 15,735 16,144 16,536 16,690 16,974 17,274 17,734 18,291
Change (%) 6.96 5.40 9.29 6.65 6.25 6.31 9.43 5.35 5.34 4.26 0.72 2.88 2.60 2.43 0.93 1.70 1.77 2.66 3.14
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 6,041 6,457 6,776 7,396 7,859 8,338 8,852 9,632 10,114 10,554 10,967 11,048 11,354 11,658 11,936 12,042 12,231 12,432 12,746 13,100
Change (%) 6.89 4.95 9.14 6.26 6.10 6.17 8.81 5.01 4.34 3.92 0.74 2.77 2.68 2.39 0.89 1.57 1.64 2.53 2.78
% of Revenue 74.77 74.72 74.40 74.30 74.02 73.91 73.81 73.39 73.15 72.46 72.22 72.24 72.16 72.21 72.18 72.15 72.06 71.97 71.87 71.62
Gross Operating Profit 2,038 2,185 2,332 2,559 2,758 2,943 3,141 3,492 3,712 4,011 4,218 4,246 4,380 4,486 4,600 4,648 4,743 4,843 4,989 5,191
Change (%) 7.18 6.74 9.72 7.80 6.69 6.71 11.20 6.30 8.05 5.15 0.67 3.16 2.40 2.54 1.06 2.04 2.10 3.02 4.06
% of Revenue 25.23 25.28 25.60 25.70 25.98 26.09 26.19 26.61 26.85 27.54 27.78 27.76 27.84 27.79 27.82 27.85 27.94 28.03 28.13 28.38
SG&A 1,849 1,959 2,082 2,214 2,338 2,451 2,587 2,781 2,922 3,149 3,308 3,431 3,577 3,680 3,779 3,836 3,938 4,041 4,199 4,399
Change (%) 5.98 6.26 6.33 5.60 4.83 5.57 7.50 5.06 7.78 5.04 3.72 4.26 2.88 2.68 1.51 2.67 2.62 3.89 4.76
% of Revenue 22.88 22.67 22.86 22.24 22.02 21.72 21.57 21.19 21.13 21.62 21.78 22.43 22.73 22.80 22.85 22.98 23.20 23.40 23.67 24.05
R&D
Change (%)
% of Revenue
OpEx 7,889 8,416 8,858 9,610 10,196 10,789 11,440 12,413 13,036 13,703 14,275 14,479 14,932 15,338 15,715 15,878 16,169 16,473 16,944 17,499
Change (%) 6.68 5.25 8.48 6.11 5.81 6.03 8.51 5.02 5.11 4.18 1.43 3.12 2.72 2.46 1.04 1.83 1.88 2.86 3.27
% of Revenue 97.65 97.39 97.26 96.54 96.04 95.64 95.39 94.58 94.28 94.08 94.01 94.67 94.90 95.01 95.04 95.13 95.26 95.36 95.54 95.67
Operating Income 190 225 250 345 421 492 553 711 790 862 910 815 803 806 821 812 805 801 790 792
Change (%) 18.83 10.93 37.97 21.96 17.06 12.41 28.50 11.16 9.03 5.57 -10.43 -1.45 0.30 1.90 -1.03 -0.94 -0.44 -1.39 0.29
% of Revenue 2.35 2.61 2.74 3.46 3.96 4.36 4.61 5.42 5.72 5.92 5.99 5.33 5.10 4.99 4.96 4.87 4.74 4.64 4.46 4.33
Interest Expense -32 -33 -34 -35 -35 -35 -36 -37 -40 -46 -51 -55 -59 -58 -57 -56 -57 -59 -61 -70
Change (%) 3.34 3.86 1.64 -0.00 1.24 2.88 3.04 6.58 15.51 10.68 9.34 6.06 -2.29 -0.37 -1.52 0.22 4.17 3.09 14.90
% of Revenue -0.39 -0.38 -0.37 -0.35 -0.33 -0.31 -0.30 -0.28 -0.29 -0.31 -0.33 -0.36 -0.37 -0.36 -0.35 -0.34 -0.33 -0.34 -0.34 -0.38
Net Income 171 194 220 295 354 407 454 580 644 700 739 661 655 666 678 681 685 681 672 662
Change (%) 13.48 13.25 33.92 20.29 14.93 11.33 27.77 11.14 8.69 5.55 -10.50 -0.89 1.61 1.82 0.49 0.54 -0.64 -1.34 -1.46
% of Revenue 2.12 2.25 2.42 2.96 3.34 3.61 3.78 4.42 4.66 4.81 4.87 4.32 4.17 4.13 4.10 4.08 4.04 3.94 3.79 3.62

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista